These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28639453)

  • 21. Unusual presentation of Rosai-Dorfman disease (RDD) in the bone in adolescents.
    Shulman S; Katzenstein H; Abramowsky C; Broecker J; Wulkan M; Shehata B
    Fetal Pediatr Pathol; 2011; 30(6):442-7. PubMed ID: 22026579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous Rosai-Dorfman disease.
    Merola JF; Pulitzer M; Rosenman K; Brownell I
    Dermatol Online J; 2008 May; 14(5):8. PubMed ID: 18627744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosai Dorfman disease--a rare entity report of two cases with nodal and extranodal involvement.
    Jalil J; Dar NR; Shafique M
    J Pak Med Assoc; 2008 Jun; 58(6):338-40. PubMed ID: 18988397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases.
    Wei C; Zhou DB
    Hematology; 2021 Dec; 26(1):552-555. PubMed ID: 34348601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosai-Dorfman disease. Extranodal sinus histiocytosis in three co-existing sites. A case report.
    Pless M; Chang BM
    J Neurooncol; 2003 Jan; 61(2):137-41. PubMed ID: 12622452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Rosai-Dorfman disease with oral bexarotene: a case series.
    Geller S; Busam K; Hamlin PA; Moskowitz AJ; Horwitz SM; Myskowski PL
    J Dermatolog Treat; 2019 Aug; 30(5):503-505. PubMed ID: 30244619
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
    Tjiu JW; Hsiao CH; Tsai TF
    Br J Dermatol; 2003 May; 148(5):1060-1. PubMed ID: 12786846
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonresectable Thoracic Rosai-Dorfman Disease: A Case Report and Review of the Literature.
    Lin CK; Tsai YD
    World Neurosurg; 2019 Dec; 132():309-313. PubMed ID: 31525482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of cutaneous Rosai-Dorfman disease with ALA-PDT combined with low-dose oral corticosteroids: A case report.
    Zhou R; Wang T; Li E; Li L
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103914. PubMed ID: 38042238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Cutaneous Rosai-Dorfman Disease and Localized Cutaneous Langerhans Cell Histiocytosis Within a Single Subcutaneous Nodule.
    Litzner BR; Subtil A; Vidal CI
    Am J Dermatopathol; 2015 Dec; 37(12):936-9. PubMed ID: 26588339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare presentation of Rosai-Dorfman-Destombes disease with central nervous system involvement and cutaneous wounds.
    Workman L; Fang L; Ayoub S; Bach K; Simman R
    J Wound Care; 2024 May; 33(Sup5):S10-S13. PubMed ID: 38683815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Singular Case of Intracranial Sinus Histiocytosis without Massive Lymphadenopathy: Isolated Rosai-Dorfman Disease of the Hypothalamus.
    Chivukula S; Clark K; Murdoch G; Engh J
    J Neurol Surg A Cent Eur Neurosurg; 2015 May; 76(3):244-8. PubMed ID: 25207593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 34. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine.
    Tasso M; Esquembre C; Blanco E; Moscardó C; Niveiro M; Payá A
    Pediatr Blood Cancer; 2006 Oct; 47(5):612-5. PubMed ID: 16302214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benign histiocytosis: Rosai-Dorfman disease].
    Noordzij W; Weernink EE; van Imhoff GW; Kluin PM; de Haan LD
    Ned Tijdschr Geneeskd; 2011; 155(27):A3176. PubMed ID: 21771370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of oral corticosteroid in Rosai-Dorfman disease.
    Ocheni S; Ibegbulam OG; Okafor OC; Raveenthiran V; Nzegwu MA
    Eur J Cancer Care (Engl); 2007 May; 16(3):286-8. PubMed ID: 17508950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosai-Dorfman disease (RDD) in the paraglottic space: report of a case and review of literature.
    Ma YL; Liang ZP; Xu SE; Yang ZH; Peng Y; Sun XQ; Qin G
    Int J Clin Exp Pathol; 2015; 8(10):13532-8. PubMed ID: 26722569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosai-Dorfman disease: three difficult-to-diagnose cases.
    Du J; Ding X; Cai L; Sun P; Zhou C; Zhang J
    Eur J Dermatol; 2010; 20(5):650-1. PubMed ID: 20621850
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous Rosai-Dorfman disease in a 42-year-old woman: a rare case report.
    D'Agostino GM; Giannoni M; Rizzetto G; Diotallevi F; Campanati A; Scarpelli M; Pepi L; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Jun; 30(2):89-90. PubMed ID: 34169708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
    Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
    Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.